Cancer cells in the tumor microenvironment secrete cytokines that interact with other cells, such as immune cells, facilitating intracellular communications and jointly moderating pathophysiological processes, including cancer-induced angiogenesis and metastasis.

Heterogeneity in cytokine production and aberrant cytokine signatures can create challenges in cancer immunotherapy.

Download this App Note to learn how Bruker Cellular Analysis helps you overcome these challenges by functionally defining each cell type to inform more effective therapies.